Argos Therapeutics (ARGSQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ARGSQ | AMGN | VRTX | REGN | BMY |
| Company | Argos Therapeutics | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 0.0350 | 317.02 | 401.54 | 931.63 | 43.90 |
| High | 0.0536 | 321.45 | 401.83 | 932.85 | 44.10 |
| Low | 0.0350 | 311.51 | 401.54 | 928.39 | 43.90 |
| Last | 0.0536 | 313.70 | 403.50 | 941.64 | 44.06 |
| Change | +0.0086 | +35.31 | +3.34 | +4.03 | +0.36 |
| % Change | +19.11% | +12.68% | +0.83% | +0.43% | +0.82% |
| Volume | 7,500 | 1,304,808 | 2,044 | 1,842 | 453,663 |
| 20-Day Average Volume | 3,825 | 2,229,896 | 969,502 | 491,307 | 13,881,868 |
| Previous Close | 0.0450 | 278.39 | 400.16 | 937.61 | 43.70 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.0558 | 272.42 | 398.47 | 908.66 | 47.46 |
| 20-Day Raw Stochastic | 66.43% | 88.23% | 67.91% | 77.86% | 7.99% |
| 20-Day Relative Strength | 46.65% | 73.08% | 47.77% | 52.60% | 29.31% |
| Weighted Alpha | -64.47 | +35.47 | +14.66 | +22.38 | -36.65 |
| Today's Opinion | 100% Sell | 24% Buy | 8% Buy | 48% Buy | 100% Sell |
| Previous Opinion | 100% Sell | 16% Sell | 8% Buy | 48% Buy | 88% Sell |
| Last Month's Opinion | 100% Sell | 24% Sell | 24% Buy | 56% Buy | 8% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -6.13% since 09/17/19 | +16.42% since 04/26/24 | +1.10% since 04/26/24 | +5.62% since 04/26/24 | -1.90% since 04/26/24 |
| Low | 0.0350 on 09/24/19 | 268.99 on 04/29/24 | 391.70 on 04/30/24 | 883.20 on 04/29/24 | 43.33 on 05/02/24 |
| High | 0.0571 on 09/18/19 | 321.45 on 05/03/24 | 406.95 on 05/01/24 | 943.77 on 05/02/24 | 45.38 on 04/29/24 |
| 1-Month | |||||
| %Chg | -14.92% since 08/21/19 | +14.53% since 04/03/24 | -1.71% since 04/03/24 | -1.91% since 04/03/24 | -15.68% since 04/03/24 |
| Low | 0.0350 on 09/24/19 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 0.0600 on 08/29/19 | 321.45 on 05/03/24 | 412.64 on 04/04/24 | 962.20 on 04/04/24 | 52.08 on 04/04/24 |
| 3-Month | |||||
| %Chg | -23.32% since 06/24/19 | -2.75% since 02/02/24 | -5.38% since 02/02/24 | -1.31% since 02/02/24 | -9.67% since 02/02/24 |
| Low | 0.0350 on 09/24/19 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 0.0699 on 06/26/19 | 329.72 on 02/05/24 | 437.00 on 02/27/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| 6-Month | |||||
| %Chg | -36.94% since 03/22/19 | +16.47% since 11/03/23 | +6.81% since 11/03/23 | +14.19% since 11/03/23 | -16.70% since 11/03/23 |
| Low | 0.0350 on 09/24/19 | 260.52 on 11/21/23 | 341.90 on 11/16/23 | 783.57 on 11/10/23 | 43.33 on 05/02/24 |
| High | 0.0900 on 03/25/19 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 567 | 149,321,728 | 103,424,960 | 102,913,952 | 88,584,272 |
| Shares Outstanding, K | 10,587 | 536,376 | 258,459 | 109,762 | 2,027,100 |
| Annual Sales | 1,900,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -40,580,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | N/A | 8,196,000,000 | 2,517,700,000 | 3,434,300,000 | 11,865,000,000 |
| Last Quarter Net Income | N/A | 767,000,000 | 968,800,000 | 1,159,600,000 | -11,911,000,000 |
| 60-Month Beta | 2.47 | 0.60 | 0.39 | 0.17 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 3.96 on 05/02/24 | 4.20 on 02/05/24 | 9.55 on 05/02/24 | -4.40 on 04/25/24 |
| Latest Earnings Date | 09/30/19 | 05/02/24 | 05/06/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | N/A | N/A | 0.600 on 04/04/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 04/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.87 | 29.92 | 24.04 | 42.10 |